Vascular Surgery Unit, 9339IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Laboratory of Research in Vascular Surgery, 9354IRCCS Istituto Auxologico Italiano, Milan, Italy.
Vascular. 2023 Feb;31(1):131-141. doi: 10.1177/17085381211058587. Epub 2021 Dec 15.
The aim of this retrospective single-center study is to describe and analyze short-, mid-, and long-term risk factors for great saphenous vein (GSV) recanalization after endovenous radiofrequency ablation (RFA).
All consecutive patients with GSV incompetence and varicose veins underwent RFA were enrolled between 2009 and 2018. Data on demographic, pre- and postoperative color Doppler scan (CDUS) findings, perioperative complications, and follow-up were prospectively collected. Primary outcome was GSV recanalization rate at 1 week after RFA. Secondary outcomes were postoperative complication rate, as well as GSV recanalization rate at 1, 3, and 5 years after RFA. Risk factors for recanalization were also analyzed, for each follow-up assessment, identifying differences in recanalized (Rec) and non-recanalized (nRec) groups.
During the study period, 1297 patients were treated. Among these, 1265 had at least 1 week of follow-up. Mean follow-up time was 3.0 ± 1.9 years. Recanalization rate at 1 week, 1, 3, and 5 years was 2.4%, 4.3%, 9.3%, and 17.5%, respectively. After multivariate analysis for each follow-up evaluation, CEAP classes C4 and 5, as well as preoperative GSV diameter >6 mm and history of smoking were found to be independent predictors of recanalization. Furthermore, age >61 years and postoperative complications such as pigmentation, edema, and paresthesia were found to be dependent risk factors.
RFA remains a safe and durable technique to ablate incompetent GSV. Despite this, particular attention should be paid to patients with high CEAP classes to avoid short and long-term recanalization.
本回顾性单中心研究旨在描述和分析静脉内射频消融(RFA)后大隐静脉(GSV)再通的短期、中期和长期风险因素。
2009 年至 2018 年期间,所有患有 GSV 功能不全和静脉曲张的连续患者均接受 RFA 治疗。前瞻性收集了人口统计学、术前和术后彩色多普勒扫描(CDUS)结果、围手术期并发症和随访数据。主要结局为 RFA 后 1 周时 GSV 再通率。次要结局为术后并发症发生率以及 RFA 后 1、3 和 5 年时 GSV 再通率。还分析了再通的(Rec)和未再通的(nRec)组之间的再通风险因素。
在研究期间,共治疗了 1297 例患者,其中 1265 例患者至少随访 1 周。平均随访时间为 3.0 ± 1.9 年。RFA 后 1 周、1 年、3 年和 5 年的再通率分别为 2.4%、4.3%、9.3%和 17.5%。在每次随访评估的多变量分析中,C4 和 5 期 CEAP 分级、术前 GSV 直径>6mm 和吸烟史被认为是再通的独立预测因素。此外,年龄>61 岁和术后并发症如色素沉着、水肿和感觉异常被认为是依赖风险因素。
RFA 仍然是一种安全且持久的消融功能不全 GSV 的技术。尽管如此,对于 CEAP 分级较高的患者应特别注意,以避免短期和长期再通。